{
  "question_stem": {
    "en": "A 46-year-old man comes to the office to follow up mixed hyperlipidemia. His lipid levels have progressively worsened over the last 10 years associated with gradual weight gain. In the last 6 months, the patient has attempted to modify his diet and exercise regimen, but his lipid levels have not improved. Past medical history is unremarkable, and he currently takes no medications. The patient does not use tobacco, alcohol, or illicit drugs. Blood pressure is 130/86 mm Hg, pulse is 76/min, and BMI is 28 kg/m². Cardiovascular examination is normal. Which of the following drugs, when used as monotherapy, would be most likely to increase triglyceride levels in this patient? {{exhibit_1}}",
    "zh": "一名46岁的男性前来就诊，随访混合性高脂血症。他的血脂水平在过去10年中逐渐恶化，并伴有体重逐渐增加。在过去的6个月里，患者尝试调整饮食和运动方案，但血脂水平并未改善。既往病史无特殊，目前未服用任何药物。患者不吸烟、不饮酒，也不吸食违禁药物。血压为130/86 mm Hg，脉搏76次/分，BMI为28 kg/m²。心血管检查正常。以下哪种药物作为单一疗法使用时，最有可能增加该患者的甘油三酯水平？{{exhibit_1}}"
  },
  "question": {
    "en": "Which of the following drugs, when used as monotherapy, would be most likely to increase triglyceride levels in this patient?",
    "zh": "以下哪种药物作为单一疗法使用时，最有可能增加该患者的甘油三酯水平？"
  },
  "options": {
    "A": {
      "en": "Atorvastatin",
      "zh": "阿托伐他汀"
    },
    "B": {
      "en": "Cholestyramine",
      "zh": "考来烯胺"
    },
    "C": {
      "en": "Ezetimibe",
      "zh": "依泽替米贝"
    },
    "D": {
      "en": "Gemfibrozil",
      "zh": "吉非贝齐"
    },
    "E": {
      "en": "Niacin",
      "zh": "烟酸"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "Bile acid-binding resins (eg, cholestyramine, colestipol, colesevelam) work by binding bile acids in the gastrointestinal tract, inhibiting enterohepatic circulation. This leads to diversion of hepatic cholesterol to synthesis of new bile acids, increased uptake of LDL cholesterol from the circulation, and reduced blood LDL levels.\n\nThe main side effects of bile acid-binding resins are gastrointestinal upset and impaired absorption of nutrients and drugs. In addition, bile acid-binding resins increase hepatic production of triglycerides and increase the release of triglyceride-heavy VLDL particles into the circulation, leading to hypertriglyceridemia.\n\n(Choice A) Statins cause modest reductions in triglyceride levels by decreasing synthesis and increasing clearance of VLDL particles.\n\n(Choice C) Ezetimibe selectively inhibits the intestinal absorption of cholesterol and lowers LDL levels. Ezetimibe does not affect triglyceride absorption but may lower blood triglyceride levels slightly.\n\n(Choice D) Fibrates (eg, gemfibrozil, fenofibrate) inhibit hepatic production of triglycerides and are first-line treatments for hypertriglyceridemia.\n\n(Choice E) Niacin reduces blood triglyceride levels, raises HDL levels, and decreases VLDL conversion to LDL, thereby decreasing LDL concentrations as well.",
    "zh": "胆汁酸结合树脂（如考来烯胺、考来替泊、消胆胺）通过结合胃肠道中的胆汁酸，抑制肝肠循环。这导致肝脏胆固醇转移至合成新的胆汁酸，增加循环中LDL胆固醇的摄取，并降低血液中的LDL水平。\n\n胆汁酸结合树脂的主要副作用是胃肠道不适以及营养素和药物的吸收受损。此外，胆汁酸结合树脂会增加肝脏对甘油三酯的产生，并增加富含甘油三酯的VLDL颗粒释放到循环中，导致高甘油三酯血症。\n\n（选项A）他汀类药物通过减少合成和增加VLDL颗粒的清除，导致甘油三酯水平适度降低。\n\n（选项C）依泽替米贝选择性地抑制肠道对胆固醇的吸收并降低LDL水平。依泽替米贝不影响甘油三酯的吸收，但可能会略微降低血液中的甘油三酯水平。\n\n（选项D）贝特类药物（如吉非贝齐、非诺贝特）抑制肝脏对甘油三酯的产生，是高甘油三酯血症的一线治疗药物。\n\n（选项E）烟酸降低血液中的甘油三酯水平，升高HDL水平，并减少VLDL转化为LDL，从而也降低LDL浓度。"
  },
  "summary": {
    "en": "This question tests knowledge of the mechanism of action and side effects of different lipid-lowering medications, specifically focusing on their impact on triglyceride levels. It requires understanding how each drug affects lipid metabolism and which one is most likely to increase triglyceride levels as a side effect.\n\nTo solve this question, recall the mechanisms of action of each drug class and their known effects on triglyceride levels. Remember that bile acid-binding resins, while lowering LDL cholesterol, can paradoxically increase triglyceride levels due to increased hepatic production of triglycerides and VLDL release.",
    "zh": "此题考察对不同降脂药物的作用机制和副作用的了解，特别关注它们对甘油三酯水平的影响。它需要理解每种药物如何影响脂质代谢，以及哪种药物最有可能作为副作用增加甘油三酯水平。\n\n为了解决这个问题，回忆每类药物的作用机制及其对甘油三酯水平的已知影响。记住，胆汁酸结合树脂虽然降低LDL胆固醇，但由于肝脏甘油三酯产生增加和VLDL释放，可能会反常地增加甘油三酯水平。"
  },
  "tags": "Hyperlipidemia; Lipid-lowering agents; Cholestyramine; Triglycerides; Bile acid-binding resins; Gastroenterology; Endocrinology; Dyslipidemia",
  "category": "Endo",
  "question_id": "163",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Endo 23\\163",
  "extracted_at": "2025-11-05T14:01:22.923138",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T17:38:11.836225",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}